Evaro secures $25M to support consumer brands in offering digital healthcare services

Evaro,
an NHS-licensed digital healthcare platform, has closed a $25 million Series A
funding round led by AlbionVC, with participation from Simplyhealth Ventures,
Exceptional Ventures, Cornerstone VC, and BBI.

Founded
by medical professionals, the company provides embeddable prescribing and
pharmacy infrastructure that enables consumer brands to offer regulated digital
healthcare services directly to their customers. The platform supports
treatment across more than 80 conditions and has served over two million
patients to date, working with a range of consumer brands.

Evaro’s
infrastructure includes asynchronous consultations, remote diagnostics,
prescribing, dispensing, and aftercare, and can be integrated into existing
digital platforms within a short timeframe. For partners, the model enables the
addition of healthcare services with limited implementation effort, while
supporting new revenue streams and deeper customer engagement.

Dr Thuria Wenbar, CEO and co-founder of Evaro, explained that the company has
developed infrastructure that allows trusted consumer brands to offer safe,
regulated healthcare for common conditions without building their own systems.

The
funding comes amid increasing pressure on primary care in the UK, driven by
extended waiting times for GP appointments. Evaro aims to help address this
demand by expanding access to regulated digital healthcare services.

Looking
ahead, the company plans to broaden its reach and further develop its
healthcare-as-a-service offering in the UK market.